{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T00:52:45Z","timestamp":1726361565692},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4 Part 1","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.juro.2015.09.084","type":"journal-article","created":{"date-parts":[[2015,10,16]],"date-time":"2015-10-16T05:07:08Z","timestamp":1444972028000},"page":"1120-1125","source":"Crossref","is-referenced-by-count":11,"title":["Circulating and Tissue Expression Levels of YKL-40 in Renal Cell Cancer"],"prefix":"10.1097","volume":"195","author":[{"given":"Frank","family":"vom Dorp","sequence":"first","affiliation":[{"name":"Department of Urology, University of Duisburg-Essen, Duisburg-Essen, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Tschirdewahn","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Duisburg-Essen, Duisburg-Essen, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Niedworok","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Duisburg-Essen, Duisburg-Essen, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henning","family":"Reis","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University of Duisburg-Essen, Duisburg-Essen, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Krause","sequence":"additional","affiliation":[{"name":"Department of Urology, Charit\u00e9, Universitaetsmedizin Berlin, Campus Benjamin Franklin and Campus Mitte, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Kempkensteffen","sequence":"additional","affiliation":[{"name":"Department of Urology, Charit\u00e9, Universitaetsmedizin Berlin, Campus Benjamin Franklin and Campus Mitte, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Busch","sequence":"additional","affiliation":[{"name":"Department of Urology, Charit\u00e9, Universitaetsmedizin Berlin, Campus Benjamin Franklin and Campus Mitte, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gero","family":"Kramer","sequence":"additional","affiliation":[{"name":"Department of Urology, Medical University of Vienna, Vienna General Hospital, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[{"name":"Department of Urology, Medical University of Vienna, Vienna General Hospital, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Nyirady","sequence":"additional","affiliation":[{"name":"Department of Urology, Semmelweis University, Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert","family":"R\u00fcbben","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Duisburg-Essen, Duisburg-Essen, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tibor","family":"Szarvas","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Duisburg-Essen, Duisburg-Essen, Berlin, Germany"},{"name":"Department of Urology, Semmelweis University, Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2015.09.084_bib1","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(09)60229-4","article-title":"Renal cell carcinoma","volume":"373","author":"Rini","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.juro.2015.09.084_bib2","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1369\/jhc.7A7245.2007","article-title":"YKL-40 protein expression in the early developing human musculoskeletal system","volume":"55","author":"Johansen","year":"2007","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.juro.2015.09.084_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10735-006-9075-0","article-title":"YKL-40 protein expression in normal adult human tissues\u2014an immunohistochemical study","volume":"38","author":"Ringsholt","year":"2007","journal-title":"J Mol Histol"},{"key":"10.1016\/j.juro.2015.09.084_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1023\/A:1024431000710","article-title":"High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival","volume":"80","author":"Johansen","year":"2003","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.juro.2015.09.084_bib5","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1002\/cncr.25196","article-title":"Elevated pretreatment serum concentration of YKL-40\u2014an independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer","volume":"116","author":"Th\u00f6m","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.juro.2015.09.084_bib6","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/pros.20311","article-title":"Prognostic value of PINP, bone alkaline phosphatase, CTX-I, and YKL-40 in patients with metastatic prostate carcinoma","volume":"66","author":"Brasso","year":"2006","journal-title":"Prostate"},{"key":"10.1016\/j.juro.2015.09.084_bib7","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/cncr.21678","article-title":"Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma","volume":"106","author":"Schmidt","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.juro.2015.09.084_bib8","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ijc.23152","article-title":"High serum levels of YKL-40 in patients with squamous cell carcinoma of the head and neck are associated with short survival","volume":"122","author":"Roslind","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.juro.2015.09.084_bib9","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ygyno.2006.08.028","article-title":"Preoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancer","volume":"104","author":"Diefenbach","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.juro.2015.09.084_bib10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/978-1-59745-447-6_7","article-title":"YKL-40: a novel marker shared by chronic inflammation and oncogenic transformation","volume":"511","author":"Roslind","year":"2009","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.juro.2015.09.084_bib11","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.urolonc.2014.02.004","article-title":"Prognostic effect of serum and tissue YKL-40 levels in bladder cancer","volume":"32","author":"Tschirdewahn","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.juro.2015.09.084_bib12","doi-asserted-by":"crossref","first-page":"41213","DOI":"10.1074\/jbc.M510146200","article-title":"Inflammatory cytokines induce production of CHI3L1 by articular chondrocytes","volume":"280","author":"Recklies","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.juro.2015.09.084_bib13","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1186\/s12885-015-1592-3","article-title":"YKL-40 regulated epithelial-mesenchymal transition and migration\/invasion enhancement in non small cell lung cancer","volume":"15","author":"Jefri","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.juro.2015.09.084_bib14","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1038\/onc.2009.292","article-title":"YKL-40, a secreted glycoprotein, promotes tumor angiogenesis","volume":"28","author":"Shao","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.juro.2015.09.084_bib15","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1038\/onc.2013.160","article-title":"Tumor-derived mural-like cells coordinate with endothelial cells: role of YKL-40 in mural cell-mediated angiogenesis","volume":"33","author":"Francescone","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.juro.2015.09.084_bib16","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s13277-014-2690-6","article-title":"Increased expression of chitinase 3-like 1 is a prognosis marker for non-small cell lung cancer correlated with tumor angiogenesis","volume":"36","author":"Wang","year":"2015","journal-title":"Tumour Biol"},{"key":"10.1016\/j.juro.2015.09.084_bib17","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1158\/1535-7163.MCT-10-0868","article-title":"A YKL-40-neutralizing antibody blocks tumor angiogenesis and progression: a potential therapeutic agent in cancers","volume":"10","author":"Faibish","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.juro.2015.09.084_bib18","series-title":"Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. World Health Organization Classification of Tumours","article-title":"Oncocytoma","author":"Reuter","year":"2004"},{"key":"10.1016\/j.juro.2015.09.084_bib19","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bjc.6602678","article-title":"Reporting recommendations for tumour MARKer prognostic studies (REMARK)","volume":"93","author":"McShane","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.juro.2015.09.084_bib20","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1002\/ijc.28808","article-title":"Prognostic value of tissue and circulating levels of IMP3 in prostate cancer","volume":"135","author":"Szarvas","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.juro.2015.09.084_bib21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.juro.2015.09.084_bib22","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.cca.2011.01.022","article-title":"Plasma YKL-40 levels in healthy subjects from the general population","volume":"412","author":"Bojesen","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.juro.2015.09.084_bib23","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/bjc.2011.347","article-title":"Breast cancer expression of YKL-40 correlates with tumour grade, poor differentiation, and other cancer markers","volume":"105","author":"Shao","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.juro.2015.09.084_bib24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2407-9-8","article-title":"YKL-40 tissue expression and plasma levels in patients with ovarian cancer","volume":"9","author":"H\u00f8gdall","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.juro.2015.09.084_bib25","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1016\/j.transproceed.2014.09.042","article-title":"YKL-40, a novel marker of cardiovascular complications, is related to kidney function in heart transplant recipients","volume":"46","author":"Przyby\u0142owski","year":"2014","journal-title":"Transplant Proc"},{"key":"10.1016\/j.juro.2015.09.084_bib26","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1158\/1055-9965.EPI-07-2766","article-title":"Diurnal, weekly, and long-time variation in serum concentrations of YKL-40 in healthy subjects","volume":"17","author":"Johansen","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.juro.2015.09.084_bib27","doi-asserted-by":"crossref","first-page":"E242","DOI":"10.5489\/cuaj.124","article-title":"Early immune outcome of retroperitoneal laparoscopic radical nephrectomy for localized renal cell carcinoma: a prospective, randomized study","volume":"6","author":"Lu","year":"2012","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.juro.2015.09.084_bib28","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.cyto.2011.03.014","article-title":"IL-6, but not TNF-\u03b1, increases plasma YKL-40 in human subjects","volume":"55","author":"Nielsen","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.juro.2015.09.084_bib29","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/cncr.10644","article-title":"High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival","volume":"95","author":"Cintin","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.juro.2015.09.084_bib30","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.eururo.2009.09.002","article-title":"Metastatic renal cell carcinoma: recent advances in the targeted therapy era","volume":"56","author":"Di Lorenzo","year":"2009","journal-title":"Eur Urol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534715049204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534715049204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2015.09.084","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T04:05:52Z","timestamp":1651205152000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2015.09.084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":30,"journal-issue":{"issue":"4 Part 1","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["10.1016\/j.juro.2015.09.084"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2015.09.084","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4]]}}}